Stock listing

Adicet Bio, Inc.

Selected listing: 0HX7 · LSE · USD · GB

Adicet Bio, Inc. (LSE:0HX7), Health Technology. Latest release Sep 28, 2026: Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly…

0HX7:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0HX7
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: USD

Latest news from Adicet Bio, Inc.

Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

September 28, 2026

Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

September 25, 2026

Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update

September 1, 2026

Adicet Bio Announces FDA Clearance of IND Application for ADI-212

August 27, 2026

Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates

August 5, 2026

All Adicet Bio, Inc. news →

Research Adicet Bio, Inc.

Adicet Bio, Inc. company profile

View the public company page for Adicet Bio, Inc. on 6ix.

Adicet Bio, Inc. news

Read company news and market updates connected to Adicet Bio, Inc..

Adicet Bio, Inc. investor events

Find investor webinars, events, and replay context for Adicet Bio, Inc..